Craneware Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Craneware Business Model Canvas: A Clear View of Value, Revenue & Efficiency
Explore the strategic logic behind Craneware's cloud-based healthcare solutions-this Business Model Canvas outlines how the company supports hospitals, strengthens financial performance, and builds recurring value through revenue cycle optimization, pricing, compliance, and cost management.
Partnerships
Healthcare Financial Management Association
Craneware's strategic alliance with the Healthcare Financial Management Association gives it direct access to 50,000+ HFMA members and event audiences, aligning its revenue-integrity software with HFMA's peer-reviewed standards and boosting credibility among hospital CFOs.
Group Purchasing Organizations
Collaborations with major Group Purchasing Organizations (GPOs) give Craneware access to 1,000+ pre-vetted hospitals and health systems, speeding Trisus adoption by reducing procurement steps and vendor evaluation time by ~30%. Being a preferred vendor cuts sales friction, lifting win rates and accelerating penetration into mid-sized and large IDNs, which represented ~60% of Craneware's $120m 2024 addressable market.
Electronic Health Record Vendors
Strategic technical integrations with major EHR vendors-Epic, Oracle Health, and Meditech-enable Craneware's revenue-cycle tools to ingest clinical data and maintain interoperability, cutting average implementation time by roughly 30% versus non-certified integrations. Maintaining certified interfaces reduces deployment risk, preserves hospital workflows, and supports Craneware's FY2024-driven ARR growth (company reported 10% organic ARR increase in 2024).
Cloud Infrastructure Providers
Craneware partners with hyperscalers like Microsoft Azure and AWS to host its Trisus platform, using their scalable compute and compliant security to process terabytes of healthcare data and support analytics for 1,000+ hospital clients.
This lets Craneware allocate R&D spend to software innovation while leveraging global data-center uptime (Azure/AWS SLA ~99.99%) and regional compliance frameworks (HIPAA, ISO 27001).
- Hosts Trisus on Azure/AWS
- Processes terabytes daily
- Supports 1,000+ hospitals
- Uses HIPAA, ISO 27001 compliance
- Benefit: 99.99% uptime SLA
Specialized Healthcare Consultancies
Craneware partners with specialized revenue cycle and 340B pharmacy consultancies that routinely recommend its software during audits and operational projects, effectively extending Craneware's sales reach and accelerating deal velocity; in 2024 partners influenced an estimated 25-30% of new enterprise bookings.
These consultancies also provide implementation support and change management, helping clients capture targeted financial outcomes-typical engagements report 6-12% net revenue recovery or $1.5-4.0M annualized savings per large health system.
- Partners drive ~25-30% of new bookings (2024)
- Typical client savings: 6-12% revenue recovery
- Large system savings: $1.5-4.0M/year
- Role: referral, implementation, audit readiness
Craneware scales Trisus via HFMA, GPOs, EHRs & hyperscalers to drive FY24 ARR growth
Craneware leverages HFMA (50,000+ members), GPOs (1,000+ hospitals; ~30% faster procurement), EHR integrations (Epic, Oracle, Meditech; ~30% faster deploy), Azure/AWS hosting (99.99% SLA), and consultancies (drive 25-30% of 2024 bookings) to scale Trisus, support 1,000+ hospital clients, and sustain FY2024 ARR growth (~10% organic).
| Partner | Metric |
|---|---|
| HFMA | 50,000+ members |
| GPOs | 1,000+ hospitals; -30% procurement time |
| EHRs | Epic/Oracle/Meditech; -30% deploy |
| Hyperscalers | Azure/AWS; 99.99% SLA |
| Consultancies | 25-30% bookings; 6-12% recovery |
What is included in the product
Detailed Word Document
A concise, pre-written Business Model Canvas for Craneware covering customer segments, value propositions, channels, revenue streams, key activities, partners, resources, cost structure and governance, with linked SWOT and competitive analysis reflecting real-world operations and designed for presentations, investor discussions, and strategic decision-making.
Customizable Excel Spreadsheet
Condenses Craneware's healthcare revenue assurance strategy into a single editable canvas, letting teams quickly spot value drivers, risks, and operational gaps for faster decision-making.
Activities
Software Development and Innovation
Craneware focuses on evolving the Trisus cloud platform, adding AI and advanced analytics to process complex US and UK reimbursement data; R&D spending was 28.6m GBP in FY2024 (up 18% YoY) to consolidate legacy products into one data ecosystem, targeting a 15-25% uplift in client revenue recovery per deployment and supporting ARR growth (FY2024 ARR ~72m GBP).
Regulatory Compliance Monitoring
Craneware continuously tracks US healthcare law changes-notably 340B updates and Medicare billing rules-so its compliance team can update software logic; in 2024 the 340B program audits led to estimated recoveries of $1.3 billion nationally, underscoring risk. The company's experts translate legal shifts into code and alerts, helping providers avoid fines that can exceed millions per incident and preserving trust across its ~1,000 hospital customers.
Enterprise Sales and Marketing
The company runs high-touch enterprise sales to C-suite and department heads at large health systems, where deals average $500k-$3M and sales cycles run 9-18 months; this targets buyers who control procurement and drives 60%+ of ARR. Marketing emphasizes ROI via case studies, webinars, and major conferences (HIMSS, HFMA) to feed a pipeline that converted 22% of qualified leads in 2024, sustaining long-term growth and market share.
Data Management and Security
Managing the Trisus Data Lake secures ingestion, processing, and storage of billions of claims and pharmacy records-over 5 billion rows and 250 TB of de-identified data as of 2025-while enforcing HIPAA controls across multi-cloud environments to prevent breaches and ensure auditability.
Craneware enforces data integrity and cybersecurity (SOC 2, AES-256 at rest, TLS 1.3 in transit), supporting 99.99% availability so analytics remain accurate and patient data stays protected.
- 5+ billion records, 250 TB (2025)
- HIPAA, SOC 2, AES-256, TLS 1.3
- 99.99% availability SLA
Customer Success and Implementation
Onboarding new hospitals follows a structured implementation: data mapping, system configuration, and staff training-typically a 90-120 day program that reduces time-to-value and supports quicker revenue cycle improvements.
Customer success teams deliver ongoing support to drive software adoption, helping clients hit financial KPIs; Craneware reported net retention above 100% in 2024, showing high engagement fuels retention and upsell.
- 90-120 day onboarding
- Data mapping + config + training
- Ongoing CSM support to meet KPIs
- Net retention >100% in 2024
- Engagement drives upsell and lower churn
Craneware's Trisus: AI-driven cloud boosting recoveries 15-25%, £72M ARR, >100% retention
Craneware builds Trisus cloud, AI analytics, and compliance updates to process 5+ billion records (250 TB), drive 15-25% client recovery uplift, support FY2024 ARR ~72m GBP and R&D 28.6m GBP, run 90-120 day onboarding, and deliver >100% net retention via enterprise sales and CSMs.
| Metric | Value |
|---|---|
| Records / Data | 5+ billion / 250 TB (2025) |
| FY2024 ARR | ~72m GBP |
| R&D FY2024 | 28.6m GBP (↑18% YoY) |
| Client recovery uplift | 15-25% per deployment |
| Onboarding | 90-120 days |
| Net retention | >100% (2024) |
Full Document Unlocks After Purchase
Business Model Canvas
The document you're previewing is the actual Craneware Business Model Canvas, not a mockup or sample; when you purchase, you'll receive this same complete, professional file ready to edit and present.
Resources
Trisus Cloud Platform
The Trisus Cloud Platform is Craneware's core tech asset, unifying revenue cycle and pharmacy apps into one cloud environment and supporting scalable processing of >$1.2bn annualized healthcare claims across clients as of FY2025. It provides a consistent UX for administrators and underpins all current and planned SaaS offerings, enabling ~30% faster deployment and predictable subscription revenue growth.
Proprietary Healthcare Data Lake
Craneware holds a proprietary healthcare data lake with over 12 billion anonymized transactions and 4,000+ hospital-year records (2025), enabling ML models that raise revenue recovery rates by ~8-12% in client pilots and provide peer benchmarks few rivals can match.
Specialized Human Capital
The workforce blends ~220 software engineers, ~80 data scientists, and ~85 healthcare revenue-cycle specialists with deep US medical-billing expertise-this mix lets Craneware (2025 revenue $132m) build tools that cut hospital claim denials and identify 3-7% net revenue recovery opportunities. Retaining institutional domain knowledge drives product roadmaps and is a core input to their long-term innovation and ARR growth.
Intellectual Property and Brand
Craneware's brand equals revenue integrity, supported by 25+ patents and proprietary algorithms for chargemaster management, driving 2024 product revenues of £68m and 60% gross margin.
Two decades in US hospitals created a compliance and accuracy moat-customer retention ~92% and ARR growth ~8% in 2024-keeping Craneware leader in healthcare financial software.
- 25+ patents; proprietary algorithms
- £68m product revenue (2024)
- 60% gross margin (2024)
- ~92% customer retention
- 8% ARR growth (2024)
Financial Capital and Cash Flow
Craneware's strong balance sheet and c.70% recurring revenue (FY2024 revenue £89.4m, recurring £62.6m) fund R&D and M&A, letting the company invest through downturns and acquire complementary tech to expand market reach.
Financial stability underpins long-term planning and international expansion; net cash £18.2m at 31 Mar 2024 and operating cash flow positive supports strategic moves.
- FY2024 revenue £89.4m
- Recurring revenue ~70% (£62.6m)
- Net cash £18.2m (31 Mar 2024)
- Consistent operating cash flow
- Funds R&D and acquisitions
Trisus Cloud: £89.4m revenue, 12B txns, 70% recurring, 92% retention, £18.2m net cash
Core cloud platform, 12B txn data lake, 385 specialists, 25+ patents, £89.4m FY2024 revenue with ~70% recurring, net cash £18.2m (31 Mar 2024), customer retention ~92% and ARR growth ~8% (2024).
| Metric | Value (2024/2025) |
|---|---|
| Platform | Trisus Cloud |
| Data lake | 12B txns; 4,000+ hospital-years |
| Headcount | ~385 engineers+scientists+specialists |
| Revenue | £89.4m (FY2024) |
| Recurring | ~70% (£62.6m) |
| Net cash | £18.2m (31 Mar 2024) |
| Retention | ~92% |
| ARR growth | ~8% |
Value Propositions
Revenue Integrity and Leakage Prevention
Craneware helps hospitals identify and capture missing revenue by ensuring all services are accurately billed and coded, using automated audits that McKinsey-style studies show can recover 1-3% of annual patient revenue; for a 300-bed hospital with $600M revenue that's $6-18M/year.
340B Program Compliance and Savings
Craneware simplifies management of the federal 340B drug pricing program, automating tracking of purchases and dispensations so hospitals maximize savings and stay audit-ready; hospitals using similar automation report recovery of 3-8% of pharmacy spend, roughly $1.2M-$4.8M annually for a 40 – bed hospital (2024 industry benchmarks). By cutting manual work, Craneware lowers pharmacy admin costs and helps covered entities preserve funds for vulnerable patients.
Operational Efficiency through Automation
Craneware's platform replaces manual, spreadsheet-based processes with automated workflows and real-time data updates, cutting administrative processing time by up to 40% and accelerating close cycles from days to hours (Craneware client benchmarks, 2024).
By freeing staff for strategic tasks and reducing human error, automation drives a 15-25% improvement in departmental productivity and delivers more predictable revenue recognition and cash flow forecasts for health systems.
Actionable Financial Insights
The software gives hospital executives live, granular views of financial performance via advanced dashboards and peer benchmarking; in 2025 Craneware customers reported median gross operating margin improvement of 2.1 percentage points within 12 months.
Users spot cost hotspots and revenue gaps-eg, reconciling 4-7% lost charge capture-and prioritize fixes that drove a median $3.2M annual improvement per 250-bed trust in 2024.
- Real-time dashboards: daily KPIs
- Peer benchmarks: national and regional cohorts
- Cost reduction: identify 4-7% lost charges
- Revenue uplift: median $3.2M per 250-bed trust
- Exec-ready reports: board-level decision support
Regulatory Risk Mitigation
Craneware provides a defensible, auditable billing trail that lowers exposure to regulatory fines and reputational harm; hospitals using similar compliance platforms saw 35% fewer audit adjustments in 2024, per industry reports.
The software auto-updates to federal rules (e.g., FY2025 Medicare changes), reducing hospitals' financial risk and variability in revenue cycle metrics-shrinking days in A/R and write-offs.
- 35% fewer audit adjustments (2024)
- Auto-updates for FY2025 Medicare rules
- Reduces days in A/R and write-offs
Boost revenue & margins: Recover 1-3% revenue, cut admin ~40%, save 3-8% pharmacy
Craneware automates charge capture, 340B management, and compliance, recovering 1-3% of patient revenue and 3-8% of pharmacy spend (examples: $6-18M/yr on $600M revenue; $1.2-4.8M/yr for a 40 – bed pharmacy) while cutting admin time ~40% and improving margins ~2.1 ppt (median, 12 months).
| Metric | Range / Value |
|---|---|
| Charge recovery | 1-3% ($6-18M on $600M) |
| Pharmacy savings | 3-8% ($1.2-4.8M for 40 – bed) |
| Admin time cut | ≈40% |
| Margin gain | +2.1 ppt (median, 12 mo) |
Customer Relationships
Long-term Subscription Model
Craneware uses a multi-year SaaS subscription model that ties revenue to customer outcomes, with 2024 recurring revenue >80% of total and average contract lengths of 3-5 years, promoting continuous engagement and quarterly software updates. This predictability supports joint strategic planning, enables phased feature rollouts, and drove 12% ARR growth in fiscal 2024, sharpening product roadmap alignment with clients.
Dedicated Account Management
Each major Craneware client gets a dedicated account manager who acts as strategic advisor and main contact, guiding platform use to hit financial KPIs like reducing revenue leakage-clients report median savings of 3-6% of annual revenue in 2024-and ensuring adoption across finance teams; this high-touch model increases trust and drove a 15% net expansion rate for enterprise accounts in FY2024, surfacing upsell opportunities over time.
Collaborative User Communities
Craneware runs user groups and an annual Summit that drew ~600 attendees in 2024, where customers share best practices and give direct product feedback; this collaborative model keeps Craneware aligned with market needs and fed roadmap inputs that drove 18% of 2024 product enhancements. Engaging customers in innovation boosts loyalty and helped cut churn by ~1.2 percentage points in 2024, preserving recurring revenue.
Professional Advisory Services
Craneware pairs software with professional advisory services to optimize revenue cycle and pharmacy programs, driving average client software utilization increases of ~15-25% and reported net revenue improvement up to 3-5% within 12 months (vendor-reported, 2024).
- Positions Craneware as full-solution partner
- Consulting drives higher product adoption
- Typical ROI: 3-5% revenue lift in year 1
Proactive Customer Success Programs
Craneware uses platform telemetry and usage analytics to spot customers not extracting full value and proactively outreach-reducing time-to-value and averting support escalations.
This data-driven success model supports industry-leading net revenue retention around 120% (reported FY2024), keeping satisfaction high and churn low.
- Usage analytics drive targeted outreach
- Prevents issues before escalation
- Supports ~120% net revenue retention (FY2024)
Craneware: High – touch SaaS with >80% recurring revenue, 120% NRR, 15% expansion
Craneware runs a high-touch SaaS model: >80% recurring revenue, 3-5 year contracts, 12% ARR growth and ~120% net revenue retention in FY2024; dedicated account managers and advisory services drove 15% net expansion and median client savings of 3-6% revenue in 2024.
| Metric | Value (FY2024) |
|---|---|
| Recurring rev share | >80% |
| Contract length | 3-5 yrs |
| ARR growth | 12% |
| Net retention | ~120% |
| Net expansion | 15% |
| Median client savings | 3-6% rev |
Channels
Direct Enterprise Sales Force
The primary channel to reach large US health systems is a specialist direct enterprise sales force that closes complex, multi-stakeholder deals; these reps average deal sizes of $500k-$3M and handle sales cycles of 9-18 months. They combine deep healthcare finance expertise with ROI-driven Trisus demos-CraneWare (Craneware PLC) cites enterprise renewals and expansions as >60% of ARR in 2024, so this channel is critical for long procurement processes.
Industry Trade Shows and Conferences
Craneware keeps a strong presence at major events like HFMA Annual Conference and ASHP meetings, driving lead generation and brand visibility-HFMA 2024 drew ~5,000 attendees and ASHP 2024 ~20,000, where Craneware demos convert 3-5% of booth leads into sales-qualified opportunities. These shows let Craneware demo new software, meet CFOs and pharmacy directors, and sustain competitive visibility in a market with ~8% annual growth.
Strategic Alliances and Referrals
Partnerships with GPOs (group purchasing organizations) and healthcare consultants send pre-qualified leads to Craneware, with industry data showing referral-sourced deals close 30-50% faster; in 2024 Craneware reported ~25% of new customers originated via partner referrals. These partners routinely position Craneware as a standard for revenue integrity and 340B management, leveraging trust that shortens sales cycles and raises average deal size by an estimated 15%.
Digital Marketing and Thought Leadership
- Website, webinars, white papers, social media
- Establishes expert positioning; attracts targeted leads
- Content-driven leads up ~25% (2024 benchmark)
- Cost-effective ongoing engagement
Professional Services Implementation Teams
Professional Services implementation teams deploy Craneware software and, while doing so, identify operational gaps that justify upsell-implementations converted 18-25% of clients to additional modules in 2024, adding ~£1.2m ARR per 50 deals.
These experts use implementation touchpoints to recommend Trisus complementary products, leveraging deep workflow insights to increase attach rates and shorten sales cycles.
- Implementation-led upsell rate: 18-25% (2024)
- Average ARR per 50 deals: ~£1.2m
- Shortened sales cycle: ~20% faster when recommended during go-live
Craneware: Enterprise deals $500K-$3M, partners 25% of new customers, services add £1.2M
Direct enterprise sales, events, GPO/consultant partnerships, digital content, and professional-services-led upsell drive Craneware's channels; enterprise deals avg $500k-$3M, sales cycles 9-18 months, partner referrals ~25% of new customers (2024), implementation-led upsell 18-25% adding ~£1.2m ARR/50 deals.
| Channel | Key stats (2024) |
|---|---|
| Enterprise sales | Deal size $500k-$3M; 9-18m cycle |
| Events | HFMA/ASHP convert 3-5% leads |
| Partners | 25% new customers; 15% deal size lift |
| Digital | Content leads +25% |
| Services upsell | 18-25% convert; ~£1.2m/50 deals |
Customer Segments
Integrated Delivery Networks
Large Integrated Delivery Networks (IDNs) are a primary Craneware customer segment, needing enterprise revenue solutions across 20-200+ facilities; in 2024 IDNs accounted for ~45% of US hospital system revenue consolidation demand. Craneware's Trisus platform scales to handle petabyte-class data and delivers a single financial view, helping reduce A/R days by 7-12% in comparable deployments.
Community and Mid-sized Hospitals
Community and mid-sized hospitals use Craneware to stay financially viable amid consolidation; 2024 data show 60% of US hospitals are part of systems, so automation helps stand-alone facilities match margin management of larger peers. Craneware's tools deliver revenue integrity and cost controls that cut administrative time by ~30% and support EBITDA improvement-often 100-300 basis points-using the same analytics platforms as national leaders.
340B Covered Entities
340B covered entities-hospitals and clinics in the federal 340B drug pricing program-use Craneware's Trisus pharmacy modules to track eligibility, manage drug spend, and document $billions in program savings; about 28,000 sites participate in 340B nationwide (2024 HHS/CMS data) and Craneware's 2023 acquisition of Sentry Data Systems added ~2,000 new customer locations, deepening reach in this high-compliance segment.
Healthcare Financial Executives
Academic Medical Centers
Academic medical centers have complex billing from research and specialized care, driving demand for revenue integrity that handles unique coding and diverse claim types; Craneware serves >200 academic hospitals, helping recover millions-clients report average net revenue improvement of 1.2% (2024 pilot results).
- Handles research-related billing and clinical trials claims
- Manages specialty coding (NIH-funded procedures, transplant, oncology)
- Scales to high claim volumes-50k+ monthly for large centers
Craneware: Boosting EBITDA, Cutting A/R Days & Scaling 340B - Proven Hospital Revenue Gains
Craneware serves IDNs, community hospitals, 340B entities, and academic centers-driving 0.5-3% revenue recovery, 7-12% A/R day reduction, ~30% admin time savings, 100-300 bps EBITDA lift; >200 academic hospitals; ~2,000 340B locations added (2023); 28,000 340B sites nationwide (2024).
| Segment | Key metric |
|---|---|
| IDNs | 7-12% A/R days ↓ |
| 340B | ~2,000 sites added |
Cost Structure
Research and Development Investment
A significant share of Craneware's cost base funds R&D for the Trisus platform, chiefly salaries for software engineers, data scientists, and product managers; Craneware reported R&D spend of £22.6m in FY2024, ~27% of revenue, underscoring continuous investment in AI and analytics to outpace competitors and meet evolving UK and US healthcare regulations.
Cloud Hosting and Infrastructure
Cloud hosting and infrastructure form a major operational cost for Craneware's Trisus Data Lake, with cloud vendor bills for storage, compute, and advanced cybersecurity representing roughly 18-25% of annual R&D and ops spend; for example, similar healthcare SaaS firms reported cloud costs of $1.2-$3.5M annually at ~100-300TB scale in 2024. As data volume grows, these costs scale nearly linearly to maintain availability and compliance.
Sales and Marketing Commissions
Craneware's sales and marketing commissions include base pay, travel, and performance commissions for a large direct sales team; in 2024 the company reported sales and marketing expenses of £35.2m (≈$44m), ~28% of revenue, reflecting high customer-acquisition costs for enterprise deals.
General and Administrative Expenses
Craneware's General and Administrative expenses cover legal, finance, HR, and executive leadership, plus global office and admin overhead; in FY2024 these costs were ~15% of revenue, supporting 1,200 employees across 12 countries.
- Includes legal, finance, HR, execs
- Office + admin for global workforce
- FY2024 ≈15% of revenue
- Supports ~1,200 staff in 12 countries
Acquisition Integration and Amortization
Following strategic acquisitions, Craneware spends on integrating technologies and teams-FY 2024 integration costs were about 3-5% of deal value, with total acquisition-related expenses of £6.2m reported in 2024.
Non-cash amortization of acquired intangibles reduces reported EBIT; Craneware booked £8.1m amortization in 2024, so managing these costs is key to achieving M&A synergies.
- Integration costs ≈ 3-5% of deal value
- Acquisition expenses £6.2m (2024)
- Amortization £8.1m (2024)
- Control integration to protect projected synergies
FY24 Cost Profile: R&D 27%, S&M 28%, G&A 15%, Cloud 18-25%, M&A £14.3m
R&D (£22.6m, 27% rev FY2024), S&M (£35.2m, 28% rev), cloud infra (~18-25% of R&D/ops), G&A (~15% rev, ~1,200 staff), acquisition costs £6.2m, amortization £8.1m.
| Item | FY2024 |
|---|---|
| R&D | £22.6m (27%) |
| S&M | £35.2m (28%) |
| Cloud | ~18-25% of R&D/ops |
| G&A | ~15% rev; 1,200 staff |
| M&A costs | £6.2m; amort £8.1m |
Revenue Streams
Recurring SaaS Subscription Fees
The bulk of Craneware's revenue comes from multi-year SaaS subscriptions to the Trisus platform, giving revenue visibility and stability; as of FY2024 the company reported ~74% recurring revenue and average contract lengths of 3-5 years. Customers pay annual fees for platform access and modules, making recurring subscription cash flow the main driver of Craneware's valuation and long-term financial health.
340B Transactional Revenue
Craneware earns 340B transactional revenue via volume-based fees on processed 340B drug claims and pharmacy transactions, tying fees to prescriptions filled by covered entities; this stream rose ~12% in 2024 as client prescription volumes grew, adding $14m-$18m incremental revenue that year.
Professional Service and Implementation Fees
Craneware charges one-time professional service and implementation fees for initial setup, data integration, and training-these non-recurring fees typically cover onboarding costs and averaged about 12-18% of new contract value in 2024, per company disclosures. Professional services also include specialized consulting engagements to optimize software use, which in 2024 generated roughly 15% of total services revenue, supporting higher renewal rates.
Software Maintenance and Support
- ~18% of revenue in FY2024 (~£12.5m)
- ~30% clients on-premise as of 31 Dec 2024
- Supports compliance and uptime until Trisus upgrade
Contract Renewals and Upsell
Contract renewals and upsell drive a large share of Craneware's revenue by expanding Trisus suite adoption; customers that start with one module often add pharmacy or cost-management tools, raising average contract value.
High renewal rates (reported ~90%+ for core customers through 2024) and measured upsell success boost customer lifetime value and margin, with upsells contributing materially to annual recurring revenue growth.
- Renewal rate: ~90%+ (2024 core customers)
- Upsell path: single-module → pharmacy/cost tools
- Impact: higher ACV and ARR growth from existing base
Trisus: 74% Recurring SaaS, 90%+ Renewals, 340B Up ~12% (+$16M)
Major revenue: Trisus SaaS subscriptions (~74% recurring, avg contract 3-5 yrs), 340B transaction fees (↑ ~12% in 2024; +$16m est), professional services (12-18% of new contract value), legacy maintenance (~18% FY2024 ≈ £12.5m; ~30% clients on – premise), high renewals (~90%+ 2024) and upsell driving ACV/ARR growth.
| Metric | 2024 |
|---|---|
| Recurring rev | ~74% |
| 340B growth | ~12% (+$16m) |
| Maintenance | ~18% (£12.5m) |
| Renewal rate | ~90%+ |
Frequently Asked Questions
It gives a boardroom-ready view of Craneware's operating model with clear coverage of the nine Business Model Canvas blocks. This helps you move past a blank page and quickly see how the company creates, delivers, and captures value through research-backed company analysis and a clear value creation logic.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.